ROCKY VIEW, Alberta, March 15, 2018 (GLOBE NEWSWIRE) -- Sundial Growers Inc. (“Sundial”) announced today that the company has entered into a Memorandum of Understanding (“MOU”) to supply up to five (5) million grams of cannabis and cannabis derivative products per year to Delta 9 Cannabis Inc. (“Delta 9”).
“This supply agreement enables Sundial to expand into the Manitoba market. We are thrilled to be able to provide Manitoba residents with quality cannabis products through Delta 9,” said Sundial’s Chief Commercial Officer, Andrew Stordeur. “Sundial applauds Delta 9 for building a strong partnership framework to ensure that Manitoba has a sufficient supply of cannabis.”
Both parties have agreed to share market data and marketing strategies in order to ensure that the production and delivery of product is optimized to meet consumer preferences and demand. The parties will also work together on product trials, marketing and branding strategies, technology services and education.
“Delta 9 is committed to working with Sundial to ensure that we meet or exceed our supply projections in order to satisfy the needs of Manitobans,” said CEO John Artbuthnot, from Delta 9. “No one can definitively predict what will happen in the cannabis market in the first year after legalization, but early indicators suggest that demand will increase dramatically, and Delta 9 intends to be ready for that demand.”
All clauses in the MOU are pending provincial regulatory structures and Health Canada approvals and regulations. Product supplied by Sundial will be subject to the terms and policies of the provincial regulatory authority within the jurisdiction of the supply agreement. Sundial is required to supply cannabis that meets or exceeds Health Canada standards and has agreed to warrantee such quality to Delta 9 and its customers.
About Sundial Growers Inc.
Sundial Growers Inc. (“Sundial”) is a privately held, Alberta-based Health Canada ACMPR-approved licensed producer of medical cannabis. Sundial combines tried and true heartland farming practices with innovative horticultural techniques to grow a select range of cannabis strains. Our focus is on producing consistent cannabis that our customers can trust.
Sundial currently operates an 31,000 square foot production facility in Rocky View, Alberta, and has two separate production facilities in various stages of completion and licensing. By 2020, we expect to be one of the leading cannabis companies in the country with a projected production of over 100 million grams of dry cannabis and over 32 million grams of concentrate or cannabis extract.
For more information about Sundial Growers Inc., visit www.sundialgrowers.com.
About Delta 9 Cannabis Inc.
Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE”.
Media Contact:
Claire Buffone-Blair, Director of Communications & Stakeholder Relations
Sundial Growers Inc.
C: 1.403.471.6378
E: claire@sundialgrowers.com
Gary Symons, Director of Communications
Delta 9 Cannabis Inc.
C: 250.300.9352
E: communications@delta9.ca